Effects of humic acid on the viability and coagulant properties of human umbilical vein endothelial cells

American Journal of Hematology

Volumn 51, Issue 3, 1996, Pages 200-206

  Yang, Hsin Ling ^a   Chiu, Hui Chong ^a   Lu, Fung Jou ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Blackfoot disease; Humic acid; Plasminogen activator inhibitor; Tissue factor; Tissue plasminogen activator

Indexed keywords

HUMIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTOCATECHUIC ACID; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLACKFOOT DISEASE; BLOOD CLOTTING; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THROMBOSIS; UMBILICAL VEIN;

ARTERIAL OCCLUSIVE DISEASES; BLOOD COAGULATION; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; HUMIC SUBSTANCES; MICROSCOPY, ELECTRON, SCANNING; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TAIWAN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL VEINS;

EID: 0029936564     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199603)51:3<200::AID-AJH4>3.0.CO;2-0     Document Type: Article

References (36)

1. Tseng WP, Chen WY, Sung JL, Chen JS: A clinical study of blackfoot disease in Taiwan, an endemic peripheral vascular disease. Mem Coll Med Natl Taiwan Univ 7:1, 1961.
2. Lu FJ, Yamamura Y, Yamauchi H: Studies on fluorescent compounds in water of a well in Blackfoot disease endemic areas in Taiwan: Humic substances. J Formosan Med Assoc 87:66, 1988.
3. Lu FJ: Fluorescent humic substances and Blackfoot disease in Taiwan. Appl Organometallic Chem 4:191, 1990.
4. Lu FJ, Lee YS: Humic acid: Inhibitor of plasmin. Sci Total Environ 114:135, 1992.
5. Chiu HC, Shih SR, Lu FJ, Yang HL: Stimulation of endothelin production in cultured human endothelial cells by fluorescent compounds associated with Blackfoot disease. Thromb Res 69:139, 1993.
6. Chiu HC, Shih SH, Lu FJ: The fluorescent compounds from drinking water and the vascular disorders of Blackfoot disease. FASEB A523:884, 1991.
7. Yang HL, Lu FJ, Wung SL, Chiu HC: Humic acid induces expression of tissue factor by cultured endothelial cells Regulation by cytosolic calcium and protein kinase C. Thromb Haemostas 71:325, 1994.
8. Hartzell S, Ryder K, Lanahan A, Lau L, Nathans D. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 9:2567, 1989.
9. Brox JH, Osterud B, Bjorklid E, Fenton JW, II: Production and availability of thromboplastin in endothelial cells: The effects of thrombin, endotoxin and platelets. Br J Haematol 57:239, 1984.
10. Hajjar KA, Hamel NM, Harpel, PC, Nachman RL: Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 80:1712, 1987.
11. Sprengers ED, Kluft C: Plasminogen activator inhibitors. Blood 69:381, 1987.
12. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA, Jr: Interteukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618, 1984.
13. Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH: The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 265:9782, 1990.
14. Scarpati EM, Sadler JE: Regulation of endothelial cell coagulant properties. J Biol Chem 264:20705, 1989.
15. Archipoff G, Beretz A, Freyssinet J, Klein-Soyer C, Brisson C, Cazenave J. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culature following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 273:679, 1991.
16. Pettersen KS, Wiiger MT, Narahara N, Andoh K, Gaudernack G, Prydz H: Induction of tissue factor synthesis in human umbilical vein endothelial cell involves protein kinase C. Thromb Haemostas 67:473, 1992.
17. Aiken NR, Thurman EM, Maleolm GL: Comparison of XAD macroporous resins for the concentration of fulvic acid from aqueous solution. Anal Chem 51:1799, 1979.
18. Hanninen KI, Klocking R, Helbig B: Synthesis and characterization of humic acid-like polymers. Science Total Environ 62:201, 1987.
19. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745, 1973.
20. Erickson LA, Schleef RR, Ny T, Loskutoff DJ: The fibrinolytic system of the vascular wall. Clin Haematol 14:513, 1985.
21. Juhan-vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D: Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 57:67, 1987.
22. Van-Hinbergh VW, Sprenger ED, Kooistra T: Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost 57:148, 1987.
23. Colucci M, Paramo JA, Collen D. Generation in plasma of a fast acting inhibitor of plasminogen inhibitor in response to endotoxin stimulation. J Clin Invest 75:818, 1985.
24. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ: Cytokine activation of vascular endothelium: Effects on tissue type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 263:5797, 1988.
25. Yang HL, Tu SC, Lu FJ, Chiu HC: Plasma protein C activity is enhanced by arsenic but inhibited by fluorescent humic acid associated with Blackfoot disease. Am J Hematol 46:64, 1994.
26. Boobis AR, Fawthrop DJ, Davies DS: Mechanisms of cell death. TIPS, 10-275, 1989.
27. 2+ in toxic cell killing. TIPS, 10:281, 1989.
28. He CJ, Peraldi MN, Adida C, Rebibou JM, Meulders Q, Sraer JD, Rondeau E: Thrombin signal transduction mechanisms in human glomerular epithelial cells. J Cell Physiol 150:475, 1992.
29. Slivka SR, Loskutoff DJ: Regulation of type I plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim Biophys Acta 1094:317, 1991.
30. Niedbala MJ, Stein-Picarella M: Role of protein kinase C in tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator. Blood 81:2608, 1993.
31. Uhl J, Newton RC, Gross JL, Rommi W, Mochan E: Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C. Biochim Biophys Acta 1097:283, 1991.
32. Jewell SA, Bellomo G, Thor H, Orremus S, Smith MT: Bleb formation in hepatocytes drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. Science 217:1257, 1982.
33. Spicer E, Horton R, Bloem L, Bach R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y, Konigsberg HA: Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA. Proc Natl Acad Sci USA 84:5148, 1987.
34. Fisher KL, Gorman CM, Vehar GA, O'Brien DP, Lawn RM: Cloning and expression of human tissue factor cDNA. Thromb Res 48:89, 1987.
35. Busso N, Huet S, Nicodeme E, Hiernaux J, Hyafil F: Refractory period phenomenon in the induction of tissue factor expression on endothelial cells. Blood 78:2027, 1991.
36. Busso N, Belin D, Failly-Crepin C, Vassali JD: Plasminogen activators and their inhibitors in mammary cell line (HBL-100): Modulation by glucocorticoids. J Biol Chem 261:9309, 1986.